ArticlePloS one2026
The prevalence of probable sarcopenia and intrinsic capacity impairment among a group of community-dwelling older people in an urban area in Cameroon.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although intrinsic capacity serves as an indirect measure of an individual's functional reserve, whether and in which way it interacts with sarcopenia is still to be addressed in Cameroon. This study aimed to describe the relationship between probable sarcopenia and domains of intrinsic capacity among older people in Cameroon. This cross-sectional study included community-dwelling older aged ≥ 60 years from two senior citizen's association in Cameroon. Probable sarcopenia was assessed using grip strength and Short Physical Performance Battery (SPPB). Screening for intrinsic capacity(IC) impairment was done using the Integrated Care to Older People(ICOPE) approach. Probable sarcopenia was defined by low handgrip strength and low physical performance. We included variables with a p-value < .1 in the multivariable analysis model. The significance level was P < .05. We included 108 participants [64.8% female, mean age (standard deviation) 70.4 (6.6) years]. The prevalence of probable sarcopenia was 34.3%. All participants had a positive screening for IC impairment and the main impaired domains were vision (88%), locomotion (61.1%) and cognition (50%). The probable sarcopenia group was likely to be older (72.9 ± 7.9 vs 69.6 ± 6.1 P = .018), achieved lower education (P = .012) and had frequent history of stroke (P = .038). After adjusting for age, sex and comorbidities, participants with impaired vitality (OR3.60, 95%CI1.08-11.94) were likely to have probable sarcopenia. Participants with preserved locomotion (OR 0.12, 95%CI 0.02-0.66) and a lower number of IC domains impaired (OR 0.52, 95%CI 0.29-0.95) were less likely to have probable sarcopenia. With regard to the components of sarcopenia, preserved locomotion (OR 0.01, 95%IC 0.012-0.07) was associated with a higher physical performance. Lower number of IC domains impaired was associated with higher physical performance (OR 0.29, 95%CI0.12-0.76) and higher handgrip strength (OR0.58, 95%CI 0.37-0.92).This study suggest that IC impairment is associated to probable sarcopenia in this group of older adults in Cameroon. Further research on IC trajectories monitoring and incident confirmed sarcopenia as outcome are needed to plan targeted interventions taking into account local resources.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.